For a better experience, click the icon above to turn off Compatibility Mode, which is only for viewing older websites.
Featuring 40+ healthcare startups seeking seed, Series A, or Series B funding, from the nationwide Coulter Translational Research Partnership university network and Philadelphia academic institutions.
Altrumed is focused on medical technologies in the harm reduction space and is developing an armband that detects an opioid overdose and automatically injects the antidote.
Non-invasive oropharynx appliance to maintain airway patency for obstructuve sleep apnea (OSA)
Avisi is developing VisiPlate, a nanotechnology-enabled implant to treat glaucoma, the leading cause of irreversible blindness that affects over 140M people worldwide.
Cogwear is creating the first clinical-grade, cognitive wearable for active situations powered by nanotechnology sensors, machine learning, and breakthrough science.
First-in-class corneal cryopreservation kit that will bring disruptive changes to the corneal transplantation market
First restorative solution to Short Bowel Syndrome via mechanical distraction enterogenesis
Pediatric-focused device company that solves medical and developmental issues in infants and children
Designed by surgeons who understand how frustrating and time-consuming it can be to search for surgical needles and sharp objects, Melzi Sharps Finder works in laparoscopic, robotic and open procedures.
Nia Therapeutics is developing personalized neurostimulation therapies for patients with memory loss due to traumatic brain injury and neurodegenerative diseases such as Alzheimer's.
Nasopharyngeal airway device designed to alleviate snoring and obstructive sleep apnea and provide a comfortable alternative to CPAP devices
Ostiio is developing a novel approach to correct craniofacial deformities and deficiencies, utilizing a fully implantable, magnetically-driven, bony distraction device.
Delivering non-thermal plasma and associate plasma chemistry directly to the skin, creating multiple high value clinical applications, including aesthetic skin rejuvenation
Rheotek Medical is developing a needle-free drug delivery platform with improved precision and dispersion of liquids.
RTM is a development-stage medical device company focused on continuous monitoring with digital data and trend analysis of critical cardiac and respiratory function in high risk patients.
Working to commercialize a next-generation ultrasonic bone fracture healing technology
vCardio is a non-invasive vFFR imaging technology to replace conventional catheter based assessments for measuring and diagnosing atherosclerotic heart disease
Ventru is improving the safety and efficacy of neurosurgical procedures through surgical instrument innovation, currently focusing on improving the accuracy of placing ventricular drains in the brain
Vital Start Health is focused on complete well-being and mental health as the fifth Vital Sign, clinically guided, measurable and personalized for each person at each stage of their care journey.
VitalCore is providing healthcare providers with a single centralized dashboard for all HL7 medical device data using existing network infrastructure which enables real-time troubleshooting of EHR data loss issues.
Single use, battery-powered, hand-held device designed for performing vitreous fluid aspiration in an office setting to enable personalized medicine in retinal diseases
Aegis Digital Health and the University of Missouri plan to partner together to solve the problem of inadequate long-term surveillance of peripheral artery disease
Comprehensive and functional biomarkers for blood testing
FloBio is developing a novel diagnostic platform to rapidly identify bleeding risk and the underlying blood clotting physiology.
Instanosis enables rapid and portable detection and quantification of extremely low concentrations of biomarkers across many diseases using simple smartphone and advanced data algorithms.
Early cancer detection using small, non-coding RNA variants found in abundance in the cell-free fraction of blood.
Neuralert offers the first non-invasive, wearable, and continuous monitoring system that detects and alerts to the onset of stroke.
Creating a paradigm shift in Tuberculosis (TB) diagnostics with an ultra-sensitive, rapid, specific and automated system to compete in the $3B annual market.
Surrogate Biopsy Device to Provide Tissue for Cancer and Solid Organ Transplant Diagnostics
Developing Electrast™, a voltage-activated ultrasound imaging agent that selectively enhances myocardial tissue and transforms standard echocardiographic images into high definition.
An affordable, ultra-portable, scientifically validated Virtual Reality solution for assessing fall risk, identifying causes and shaping treatments.
Vasowatch is developing a wearable medical device for early detection of postpartum hemorrhage to make childbirth safer for women.
We are a pharmaceutical start-up focusing on bringing new cannabinoid therapeutics for the treatment of chronic pain, anxiety, and seizure disorders to market.
Reversing Skin Aging Through Senescent Modulation
Cantius’ unique peptide-based therapeutics target the treatment of cachexia, emesis, glycemic control and weight-loss.
Building the future through microfluidics: A world where gene therapies are the standard - and not the exception - in healthcare
Duet Therapeutics is developing a new class of medications to treat diabetic and other retinopathies, the leading causes of blindness.
Dedicated to the discovery and development of new treatments for cancer based on reprogramming the epigenome.
Intact Therapeutics is developing innovative targeted therapies for digestive diseases
It is development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs.
Platelet-inspired therapies for the treatment of bleeding and other blood-related ailments
Trevarx is developing theranostic platforms that turn deadly diseases such as ovarian, breast and prostate cancers into manageable conditions.
Cerillo designs innovative laboratory products that allow researchers to explore the outer limits of their scientific imaginations.
The Coulter Investment Forum brings together innovative companies in the areas of medical devices, therapeutics and diagnostics, healthcare IT, and delivery solutions.